528 related articles for article (PubMed ID: 33789695)
1. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
Vill K; Schwartz O; Blaschek A; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Czibere L; Durner J; Eggermann K; Olgemöller B; Harms E; Schara U; Kölbel H; Müller-Felber W
Orphanet J Rare Dis; 2021 Mar; 16(1):153. PubMed ID: 33789695
[TBL] [Abstract][Full Text] [Related]
2. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
[TBL] [Abstract][Full Text] [Related]
3. Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?
Müller-Felber W; Vill K; Schwartz O; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Durner J; Eggermann K; Müller C; Hannibal I; Olgemöller B; Schara U; Blaschek A; Kölbel H
J Neuromuscul Dis; 2020; 7(2):109-117. PubMed ID: 32144995
[TBL] [Abstract][Full Text] [Related]
4. Newborn screening for spinal muscular atrophy: The Wisconsin first year experience.
Baker MW; Mochal ST; Dawe SJ; Wiberley-Bradford AE; Cogley MF; Zeitler BR; Piro ZD; Harmelink MM; Kwon JM
Neuromuscul Disord; 2022 Feb; 32(2):135-141. PubMed ID: 35120759
[TBL] [Abstract][Full Text] [Related]
5. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
[TBL] [Abstract][Full Text] [Related]
6. Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
Glascock J; Sampson J; Haidet-Phillips A; Connolly A; Darras B; Day J; Finkel R; Howell RR; Klinger K; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
J Neuromuscul Dis; 2018; 5(2):145-158. PubMed ID: 29614695
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns.
Efimova IY; Zinchenko RA; Marakhonov AV; Balinova NV; Mikhalchuk KA; Shchagina OA; Polyakov AV; Mudaeva DA; Saydaeva DH; Matulevich SA; Parshintseva PD; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Jamschikova AV; Nurgalieva LR; Saifullina EV; Nevmerzhitskaya KS; Belyaeva TI; Romanova OS; Voronin SV; Kutsev SI
Pediatr Neurol; 2024 Jul; 156():147-154. PubMed ID: 38781723
[TBL] [Abstract][Full Text] [Related]
8. Spinal Muscular Atrophy - Is Newborn Screening Too Late for Children with Two SMN2 Copies?
Schwartz O; Kölbel H; Blaschek A; Gläser D; Burggraf S; Röschinger W; Schara U; Müller-Felber W; Vill K
J Neuromuscul Dis; 2022; 9(3):389-396. PubMed ID: 35431259
[TBL] [Abstract][Full Text] [Related]
9. Newborn Screening for SMA - Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies?
Blaschek A; Kölbel H; Schwartz O; Köhler C; Gläser D; Eggermann K; Hannibal I; Schara-Schmidt U; Müller-Felber W; Vill K
J Neuromuscul Dis; 2022; 9(5):597-605. PubMed ID: 35848034
[TBL] [Abstract][Full Text] [Related]
10. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.
Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B
Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for spinal muscular atrophy by calibrated short-amplicon melt profiling.
Dobrowolski SF; Pham HT; Downes FP; Prior TW; Naylor EW; Swoboda KJ
Clin Chem; 2012 Jun; 58(6):1033-9. PubMed ID: 22490618
[TBL] [Abstract][Full Text] [Related]
13. Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy.
Kay DM; Stevens CF; Parker A; Saavedra-Matiz CA; Sack V; Chung WK; Chiriboga CA; Engelstad K; Laureta E; Farooq O; Ciafaloni E; Lee BH; Malek S; Treidler S; Anziska Y; Delfiner L; Sakonju A; Caggana M
Genet Med; 2020 Aug; 22(8):1296-1302. PubMed ID: 32418989
[TBL] [Abstract][Full Text] [Related]
14. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of population-based newborn screening for spinal muscular atrophy in New York state.
Kraszewski JN; Kay DM; Stevens CF; Koval C; Haser B; Ortiz V; Albertorio A; Cohen LL; Jain R; Andrew SP; Young SD; LaMarca NM; De Vivo DC; Caggana M; Chung WK
Genet Med; 2018 Jun; 20(6):608-613. PubMed ID: 29758563
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Reference Materials for Spinal Muscular Atrophy Genetic Testing: A Genetic Testing Reference Materials Coordination Program Collaborative Project.
Prior TW; Bayrak-Toydemir P; Lynnes TC; Mao R; Metcalf JD; Muralidharan K; Iwata-Otsubo A; Pham HT; Pratt VM; Qureshi S; Requesens D; Shen J; Vetrini F; Kalman L
J Mol Diagn; 2021 Jan; 23(1):103-110. PubMed ID: 33197628
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counselling.
Rudnik-Schöneborn S; Berg C; Zerres K; Betzler C; Grimm T; Eggermann T; Eggermann K; Wirth R; Wirth B; Heller R
Clin Genet; 2009 Aug; 76(2):168-78. PubMed ID: 19780763
[TBL] [Abstract][Full Text] [Related]
18. The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy: Observational study.
Zhang Y; He J; Zhang Y; Li L; Tang X; Wang L; Guo J; Jin C; Tighe S; Zhang Y; Zhu Y; Zhu B
Medicine (Baltimore); 2020 Jan; 99(3):e18809. PubMed ID: 32011487
[TBL] [Abstract][Full Text] [Related]
19. Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy.
Lusakowska A; Jedrzejowska M; Kaminska A; Janiszewska K; Grochowski P; Zimowski J; Sierdzinski J; Kostera-Pruszczyk A
Orphanet J Rare Dis; 2021 Mar; 16(1):150. PubMed ID: 33761963
[TBL] [Abstract][Full Text] [Related]
20. Early spinal muscular atrophy treatment following newborn screening: A 20-month review of the first Italian regional experience.
Gagliardi D; Canzio E; Orsini P; Conti P; Sinisi V; Maggiore C; Santarsia MC; Lagioia G; Lupis G; Roppa I; Scianatico G; Mancini D; Corti S; Comi GP; Gentile M; Gagliardi D
Ann Clin Transl Neurol; 2024 May; 11(5):1090-1096. PubMed ID: 38600653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
